Sum Wai Eldwin Tan

Title: Innovations by Sum Wai Eldwin Tan

Introduction

Sum Wai Eldwin Tan is a notable inventor based in Singapore, SG. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific disorders. His work is recognized for its potential therapeutic applications, especially in treating serious health conditions.

Latest Patents

Tan holds a patent for "Compounds useful as inhibitors of isoprenylcysteine carboxyl methyltransferase." This invention relates to compounds of general Formula (I), including their tautomers, enantiomers, solvates, hydrates, and pharmaceutically acceptable salts. The patent outlines the use of these compounds in therapy, specifically for treating isoprenylcysteine carboxyl methyltransferase (ICMT) related disorders, including cancer and progeria. Additionally, it details processes for synthesizing these compounds, showcasing Tan's innovative approach to addressing critical health issues.

Career Highlights

Tan is affiliated with the Agency for Science, Technology and Research, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies and drug development.

Collaborations

Tan collaborates with esteemed colleagues, including Soo Yei Ho and Anders Poulsen. These partnerships enhance the research environment and contribute to the innovative outcomes of their projects.

Conclusion

Sum Wai Eldwin Tan's contributions to medicinal chemistry and his innovative patent demonstrate his commitment to advancing healthcare solutions. His work exemplifies the importance of research in developing effective treatments for complex disorders.